Please login to the form below

Not currently logged in
Email:
Password:

CMA

This page shows the latest CMA news and features for those working in and with pharma, biotech and healthcare.

Roche to close $4.3bn Spark deal after FTC clearance

Roche to close $4.3bn Spark deal after FTC clearance

The main concern posed by the CMA and the FTC is that the newly merged company could have an overly dominant position in the haemophilia A market. ... The FTC and CMA investigation into the merger was a surprise for not only Spark, but the entire pharma

Latest news

  • UK’s CMA clears Roche’s $4.3bn takeover of Spark UK’s CMA clears Roche’s $4.3bn takeover of Spark

    Roche first announced its intention to acquire Spark in February, but has had to keep pushing back the completion date as the FTC in the US and the CMA in the ... In a statement from the CMA, the antitrust authority said: “While gene therapy treatments

  • Pfizer, Flynn face reinstatement of £90m CMA fine Pfizer, Flynn face reinstatement of £90m CMA fine

    The case dates back to 2015, when the Competition and Markets Authority (CMA)   accused the two companies of dramatically raising the price of phenytoin sodium, a drug that has been used ... A  report in the Financial Times says the CMA is arguing

  • Roche moving closer to approval of Spark takeover; report Roche moving closer to approval of Spark takeover; report

    Competition and Markets Authority (CMA) have taken their time to probe antitrust issued raised by the deal. ... The CMA has set a deadline of mid-December for a decision on the first phase of its review of the acquisition, which could be the end of the

  • UK government raises concerns about Illumina’s $1.2bn takeover of PacBio UK government raises concerns about Illumina’s $1.2bn takeover of PacBio

    added. Following the CMA's provisional findings, it has invited comments on possible remedies by 7 November 2019. ... Illumina had originally planned to close the transaction in mid-2019, but this was stalled by the CMA's investigation, which began in

  • Aspen to pay millions to NHS following drug pricing investigation Aspen to pay millions to NHS following drug pricing investigation

    According to the CMA, thousands of patients rely on the medicine, which is used to treat primary or secondary adrenal insufficiency (Addison’s Disease). ... Following the investigation, the CMA has accepted Aspen’s offer of commitments to resolve a

More from news
Approximately 5 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics